Related Experiment Video
Updated: Jun 7, 2026
06:32
Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
Cancer-associated IDH mutations: biomarker and therapeutic opportunities
K E Yen1, M A Bittinger, S M Su
1Molecular Oncology, Agios Pharmaceuticals, Cambridge, MA 02139, USA.
Oncogene
|October 26, 2010
Summary
Somatic mutations in isocitrate dehydrogenase (IDH) enzymes in glioblastoma alter their function, leading to D-2-hydroxyglutarate (D-2HG) production. These IDH mutations are significant in glioma and hematologic malignancies.
Area of Science:
- Biochemistry
- Cancer Biology
- Genetics
Background:
- Somatic mutations in isocitrate dehydrogenase (IDH) enzymes were discovered in glioblastoma.
- These mutations occur at arginine residues critical for substrate binding.
- The discovery marked a significant event in cancer biology.
Purpose of the Study:
- To investigate the impact of IDH mutations on enzyme activity.
- To understand the novel enzymatic activity conferred by these mutations.
- To discuss the role of D-2HG in tumorigenesis and therapeutic potential.
Main Methods:
- Genome-wide mutational analysis in glioblastoma.
- Biochemical assays to study enzyme activity.
- Analysis of prognostic value across malignancies.
Main Results:
- IDH1 and IDH2 mutations impair isocitrate to α-ketoglutarate (αKG) conversion.
- Mutant IDH enzymes gain activity to reduce αKG to D-2-hydroxyglutarate (D-2HG).
- IDH mutations show prognostic value in glioma and hematologic malignancies.
Conclusions:
- Mutant IDH enzymes have altered biochemical functions.
- Elevated D-2HG levels are implicated in tumorigenesis.
- Targeting mutant IDH enzymes presents therapeutic potential.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...